These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 11752034)

  • 21. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects.
    Schulze F; Maas R; Freese R; Schwedhelm E; Silberhorn E; Böger RH
    Eur J Clin Invest; 2005 Oct; 35(10):622-6. PubMed ID: 16178881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy.
    Päivä H; Lehtimäki T; Laakso J; Ruokonen I; Rantalaiho V; Wirta O; Pasternack A; Laaksonen R
    Metabolism; 2003 Mar; 52(3):303-7. PubMed ID: 12647267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE; Syme HM; Vallance C; Elliott J
    J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of renal function on homeostasis of asymmetric dimethylarginine (ADMA): studies in donors and recipients of renal transplants.
    Said MY; Douwes RM; van Londen M; Minović I; Frenay AR; de Borst MH; van den Berg E; Heiner-Fokkema MR; Kayacelebi AA; Bollenbach A; van Goor H; Navis G; Tsikas D; Bakker SJL
    Amino Acids; 2019 Mar; 51(3):565-575. PubMed ID: 30610470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.
    Uzun H; Konukoglu D; Besler M; Erdenen F; Sezgin C; Muderrisoglu C
    Clin Invest Med; 2008; 31(1):E1-7. PubMed ID: 18312743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
    J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease.
    Young JM; Terrin N; Wang X; Greene T; Beck GJ; Kusek JW; Collins AJ; Sarnak MJ; Menon V
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1115-20. PubMed ID: 19389824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
    Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity].
    Galiamov MG; Saginova EA; Severova MM; Samokhodskaia LM; Krasnova TN; Sholomova VI; Sorokin IuD; Mukhin NA
    Ter Arkh; 2013; 85(6):31-7. PubMed ID: 23866596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
    Ronden RA; Houben AJ; Teerlink T; Bakker JA; Bierau J; Stehouwer CD; De Leeuw PW; Kroon AA
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F149-56. PubMed ID: 22552932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans.
    Kielstein JT; Impraim B; Simmel S; Bode-Böger SM; Tsikas D; Frölich JC; Hoeper MM; Haller H; Fliser D
    Circulation; 2004 Jan; 109(2):172-7. PubMed ID: 14662708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients.
    Fujii H; Takiuchi S; Kawano Y; Fukagawa M
    Am J Hypertens; 2008 Jun; 21(6):650-6. PubMed ID: 18443575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.
    Fleck C; Schweitzer F; Karge E; Busch M; Stein G
    Clin Chim Acta; 2003 Oct; 336(1-2):1-12. PubMed ID: 14500028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial.
    Teplan V; Schück O; Racek J; Mareckova O; Stollova M; Hanzal V; Malý J
    Wien Klin Wochenschr; 2008; 120(15-16):478-85. PubMed ID: 18820852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension.
    Wang D; Strandgaard S; Iversen J; Wilcox CS
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R195-200. PubMed ID: 18685064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.